EP0666752A4 - Therapeutische mikroemulsionen. - Google Patents

Therapeutische mikroemulsionen.

Info

Publication number
EP0666752A4
EP0666752A4 EP93923933A EP93923933A EP0666752A4 EP 0666752 A4 EP0666752 A4 EP 0666752A4 EP 93923933 A EP93923933 A EP 93923933A EP 93923933 A EP93923933 A EP 93923933A EP 0666752 A4 EP0666752 A4 EP 0666752A4
Authority
EP
European Patent Office
Prior art keywords
microemulsions
therapeutic
therapeutic microemulsions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP93923933A
Other languages
English (en)
French (fr)
Other versions
EP0666752A1 (de
Inventor
Panayiotis Peri Constantinides
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Publication of EP0666752A1 publication Critical patent/EP0666752A1/de
Publication of EP0666752A4 publication Critical patent/EP0666752A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08Peptides having 5 to 11 amino acids
    • A61K38/095Oxytocins; Vasopressins; Related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/25Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP93923933A 1992-10-16 1993-10-15 Therapeutische mikroemulsionen. Withdrawn EP0666752A4 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US96295792A 1992-10-16 1992-10-16
US962957 1992-10-16
PCT/US1993/009963 WO1994008605A1 (en) 1992-10-16 1993-10-15 Therapeutic microemulsions

Publications (2)

Publication Number Publication Date
EP0666752A1 EP0666752A1 (de) 1995-08-16
EP0666752A4 true EP0666752A4 (de) 1996-09-11

Family

ID=25506555

Family Applications (1)

Application Number Title Priority Date Filing Date
EP93923933A Withdrawn EP0666752A4 (de) 1992-10-16 1993-10-15 Therapeutische mikroemulsionen.

Country Status (3)

Country Link
EP (1) EP0666752A4 (de)
JP (1) JPH08502492A (de)
WO (1) WO1994008605A1 (de)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992018147A1 (en) * 1991-04-19 1992-10-29 Affinity Biotech, Inc. Convertible microemulsion formulations
US5688761A (en) * 1991-04-19 1997-11-18 Lds Technologies, Inc. Convertible microemulsion formulations
US6395494B1 (en) 1993-05-13 2002-05-28 Neorx Corporation Method to determine TGF-β
US5981568A (en) 1993-01-28 1999-11-09 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
TW438603B (en) * 1993-04-19 2001-06-07 Advanced Skin Res Kenkyusho Kk Microemulsion preparation containing peptide pharmaceuticals
WO1994026303A1 (en) * 1993-05-13 1994-11-24 Neorx Corporation Prevention and treatment of pathologies associated with abnormally proliferative smooth muscle cells
CA2185803C (en) * 1994-03-18 2006-07-11 Edward M. Rudnic Emulsified drug delivery systems
HU215966B (hu) * 1994-11-21 1999-07-28 BIOGAL Gyógyszergyár Rt. Orálisan alkalmazható, ciklosporint tartalmazó, összetett emulzió-előkoncentrátum
AU698317B2 (en) 1995-02-25 1998-10-29 Cancer Research Technology Limited Transgenic animals as model of psoriasis
US5824638A (en) * 1995-05-22 1998-10-20 Shire Laboratories, Inc. Oral insulin delivery
US6008228A (en) * 1995-06-06 1999-12-28 Hoffman-La Roche Inc. Pharmaceutical compositions containing proteinase inhibitors
US5734770A (en) * 1995-06-29 1998-03-31 Minnesota Mining And Manufacturing Company Cleave and bevel fiber optic connector
US5660858A (en) * 1996-04-03 1997-08-26 Research Triangle Pharmaceuticals Cyclosporin emulsions
GB9613858D0 (en) 1996-07-02 1996-09-04 Cortecs Ltd Hydrophobic preparations
WO1998022089A1 (en) * 1996-11-22 1998-05-28 Pharmacia & Upjohn Ab Pharmaceutical composition based on a lipid matrix system
ATE278397T1 (de) 1997-03-31 2004-10-15 Boston Scient Ltd Verwendung von cytoskelettinhibitoren zur vorbeugung der restenose
KR100587551B1 (ko) 1997-12-10 2006-06-08 싸이클로스포린 테라퓨틱스 리미티드 오메가-3 지방산 오일을 함유하는 약학 조성물
US6979456B1 (en) 1998-04-01 2005-12-27 Jagotec Ag Anticancer compositions
WO1999053941A1 (fr) * 1998-04-15 1999-10-28 Shionogi & Co., Ltd. Preparations orales contenant des derives de trh
DE10024451A1 (de) * 2000-05-18 2001-11-29 Asta Medica Ag Pharmazeutische Darreichungsform für Peptide, Verfahren zu deren Herstellung und Verwendung
US20020155084A1 (en) * 2000-06-02 2002-10-24 The Regents Of The University Of The Michigan Nanoemulsion formulations
CN1160122C (zh) 2001-04-20 2004-08-04 清华大学 一种制备口服胰岛素油相制剂的方法
US6613083B2 (en) 2001-05-02 2003-09-02 Eckhard Alt Stent device and method
EP2116228A1 (de) 2001-10-19 2009-11-11 Isotechnika Inc. Neuartige Cyclosporinanalog-Mikroemulsionspräkonzentrate
RO123110B1 (ro) * 2001-12-14 2010-11-30 Jagotec Ag Formulare farmaceutică cu ciclosporină şi utilizarea acesteia
PE20050596A1 (es) * 2003-12-19 2005-10-18 Novartis Ag Microemulsion que comprende un inhibidor renina
ES2314646T3 (es) 2004-03-22 2009-03-16 Solvay Pharmaceuticals Gmbh Composiciones farmaceuticas por via de productos que contienen lipasa , en particular de pancreatina, que contienen tensioactivos.
US9743680B2 (en) * 2005-10-14 2017-08-29 Wild Flavors, Inc. Microemulsions for use in food and beverage products
EP1961412A1 (de) 2006-12-27 2008-08-27 LEK Pharmaceuticals D.D. Selbstmikroemulgierende Arzneimittelabgabesysteme
US20110144010A1 (en) * 2007-06-01 2011-06-16 Novo Nordisk A/S Spontaneously Dispersible Preconcentrates Including a Peptide Drug in a Solid or Semisolid Carrier
WO2009115469A1 (en) 2008-03-18 2009-09-24 Novo Nordisk A/S Protease stabilized, acylated insulin analogues
GB201107630D0 (en) * 2011-05-06 2011-06-22 Proxima Concepts Ltd Microemulsions
CA2870313A1 (en) 2012-04-11 2013-10-17 Novo Nordisk A/S Insulin formulations
ES2886837T3 (es) 2016-12-16 2021-12-21 Novo Nordisk As Composiciones farmacéuticas que contienen insulina
KR101991661B1 (ko) * 2017-03-02 2019-06-21 대화제약 주식회사 자나미비르를 포함하는 안정한 약제학적 조성물
WO2018159941A1 (ko) * 2017-03-02 2018-09-07 대화제약 주식회사 자나미비르를 포함하는 안정한 약제학적 조성물

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4146499A (en) * 1976-09-18 1979-03-27 Rosano Henri L Method for preparing microemulsions
EP0278660A1 (de) * 1987-02-03 1988-08-17 Stiefel Laboratories (Ireland) Limited Mikroemulsionen
EP0387647A2 (de) * 1989-03-13 1990-09-19 Desitin Arzneimittel GmbH Hochdisperse pharmazeutische Zusammensetzung
WO1991018669A1 (en) * 1990-06-08 1991-12-12 Affinity Biotech, Inc. Process for preparing microemulsion
WO1992018147A1 (en) * 1991-04-19 1992-10-29 Affinity Biotech, Inc. Convertible microemulsion formulations
WO1993002665A1 (en) * 1991-07-26 1993-02-18 Smithkline Beecham Corporation W/o microemulsions
WO1993002664A1 (en) * 1991-07-26 1993-02-18 Smithkline Beecham Corporation W/o microemulsions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5110606A (en) * 1990-11-13 1992-05-05 Affinity Biotech, Inc. Non-aqueous microemulsions for drug delivery

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4146499A (en) * 1976-09-18 1979-03-27 Rosano Henri L Method for preparing microemulsions
EP0278660A1 (de) * 1987-02-03 1988-08-17 Stiefel Laboratories (Ireland) Limited Mikroemulsionen
EP0387647A2 (de) * 1989-03-13 1990-09-19 Desitin Arzneimittel GmbH Hochdisperse pharmazeutische Zusammensetzung
WO1991018669A1 (en) * 1990-06-08 1991-12-12 Affinity Biotech, Inc. Process for preparing microemulsion
WO1992018147A1 (en) * 1991-04-19 1992-10-29 Affinity Biotech, Inc. Convertible microemulsion formulations
WO1993002665A1 (en) * 1991-07-26 1993-02-18 Smithkline Beecham Corporation W/o microemulsions
WO1993002664A1 (en) * 1991-07-26 1993-02-18 Smithkline Beecham Corporation W/o microemulsions

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO9408605A1 *

Also Published As

Publication number Publication date
WO1994008605A1 (en) 1994-04-28
EP0666752A1 (de) 1995-08-16
JPH08502492A (ja) 1996-03-19

Similar Documents

Publication Publication Date Title
EP0597463A3 (en) Thermotherapiesonde.
EP0580285A3 (de) Selbsttätige Wiedereinschalter.
GR3025363T3 (en) Medicaments.
GR3022484T3 (en) Osteosynthesis aid.
AU116235S (en) Chair
ZA927562B (en) Medicament.
EP0676156A4 (de) Stuhl.
EP0684834A4 (de) Mikroemulsionen, die therapeutische peptide enthalten.
EP0684833A4 (de) Mikroemulsionen mit therapeutischen peptiden.
ZA926220B (en) Microemulsions
EP0646342A3 (de) Stuhl.
EP0599191A3 (de) Motordrehzahlregler-Schaltkreis.
EP0599077A3 (de) Anti-metastatischer Impfstoff.
AU116238S (en) Chair
PH31659A (en) Therapeutic nucleotides.
ZA935828B (en) New insobutyl-substituted methanesulphonyl-quinolyl-methoxyphenyl-cycloalkylacetamides.
EP0624089A4 (en) Methods.
ZA921092B (en) Microemulsions
EP0662782A4 (de) Pp14-basierte therapie.
ZA939564B (en) Vaccines.
EP0681480A4 (de) Recognin vakzine.
ZA929916B (en) Therapeutic agents.
ZA93236B (en) Babesial rhoptry antigens.
EG19223A (en) Therapeutic agents.
ZA933136B (en) Therapeutic alcohols.

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19950510

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): BE CH DE FR GB IT LI NL

RHK1 Main classification (correction)

Ipc: A61K 38/00

RHK1 Main classification (correction)

Ipc: A61K 37/00

A4 Supplementary search report drawn up and despatched

Effective date: 19960729

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): BE CH DE FR GB IT LI NL

17Q First examination report despatched

Effective date: 19980925

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19990206